Linvoseltamab,Elotuzumab,Pomalidomide,Dexamethasone
Regeneron,AbbVie,BMS
['linvoseltamab', 'mmsm']
linvoseltamab shows high response rate, manageable toxicity for pretreated myeloma #asco23 #asco2023 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.